Johnson & Johnson Overview
Valuation check: JNJ.TO's PEG ratio is -31.54, below the Healthcare sector average of 0.46.
Get informed when a big investor buys or sells
+ Follow-31.54
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for JNJ.TO is -31.54. That is below the Healthcare sector average of 0.46. Investors often review this figure alongside Johnson & Johnson's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, JNJ.TO currently prints -31.54 for PEG ratio, while the sector average sits near 0.46. That is roughly 6903.4% below the sector mean. Large gaps often invite a closer look at Johnson & Johnson's growth, margins, and balance sheet.
A PEG ratio of -31.54 for Johnson & Johnson is not 'good' or 'bad' on its own. Compare it with the peer average (0.46) and with JNJ.TO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting JNJ.TO's PEG ratio (-31.54), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Johnson & Johnson's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
